What is CBD Hemp oil and how does it work?
Industrial hemp and the cannabis drug, marijuana are both members of the Cannabis sativa species, however from there they have distinctive biochemical compositions and uses.
Cannabidiol (CBD) derived from hemp oil is truly one of the most remarkable compounds in the natural world and the CBD oil we sell is derived from Hemp with a .03% THC (tetrahydrocannabinol) and .03% or less is legal in all 50 states. Unlike marijuana which possesses high percentages of THC (the psychotropic ingredient), CBD from hemp does not. The more we learn about CBD, the more it seems poised to revolutionize medicine as we know it.
Our bodies are composed of a series of neurological networks called the endocannibinoid system, and it’s loaded with receptors that bind to the CBD you introduce to your bloodstream.
When the CBD binds to the endocannabinoid system’s receptors, it influences many of the body’s major systems and helps relieve the various symptoms being described below.
Here’s a quick overview of the major studies and most promising findings about the medical importance of CBD.
Here’s What CBD Hemp Oil is being used for, and the research to back it up.
CBD Oil for Pain and Arthritis Relief
Medical cannabis is quickly becoming the go-to alternative to dangerous and addictive prescription painkillers, like morphine, oxycodone and many opioids that create addictions and have side effects.
While cannibis with psycho-active THC has received a lot of attention for relieving pain, CBD is also a potent pain reliever. 2015 saw the most important study to uncover the pain-relieving effects of CBD. In that study, researchers compared cannabidiol to morphine.
To their surprise, CBD worked well in combination with morphine and counteracted the latter’s risky side effects. This means cannabidiol can help treat acute pain conditions, along with more long-term benefits.
Diabetic Neuropathy and Neurological Diseases
CBD binds with the endocannabinoid system to produce a response that reduces nerve inflammation. This is another of its “neuroprotective” qualities and a major reason why CBD is such an effective treatment for neurological diseases.
Relieving Stress, Anxiety, Post Traumatic Stress Disorder (PTSD), Supporting Sleep and Depression
Post Traumatic Stress Disorder (PTSD) affects nearly 8 percent of all American’s during their lifetime. Women are twice as likely as men to suffer from it. Finding an affordable, safe, and reliable treatment for PTSD would profoundly impact the lives of millions of Americans every year.
To that end, a pathbreaking 2013 study found that cannabidiol improved people’s abilities to forget their traumatic memories. These findings are incredibly important and could be relevant in helping to understand how and why CBD helps people sleep more deeply, reduces stress and anxiety and helps reduce symptoms of various mood disorders.
Epileptic Seizures Stopped
One of the most important CBD studies ever published was a path-breaking study into the efficacy of using CBD as a treatment for epilepsy.
In 2012, researchers with the British Epilepsy Association published a paper called “Cannabidiol exerts anticonvulsant effects in animal models of the temporal lobe and partial seizures.” Their conclusion? “The evidence strongly supports CBD as a therapeutic candidate for a diverse range of human epilepsies.”
Neurological Diseases Like Alzheimer’s, Multiple Sclerosis, and Parkinson’s
Researchers are still trying to figure out the exact mechanisms behind neurodegenerative diseases like Alzheimer’s. We know it has to do with a protein pathway, and that’s exactly the pathway this 2006 study investigates.
Taking a look down to the molecular level, researchers discovered that CBD can actually protect nerve cells from degenerative diseases. Scientists call this CBD’s “neuroprotective effect,” and it’s one of the most promising aspects of the cannabinoid.
Pre-clinical trials have shown that CBD has a powerful anti-tumor effect. The most important study to reveal these powerful tumor-inhibiting effects came out in 2015. In fact, this study looked at a range of non-psychoactive cannabinoids.
In a landmark for medical cannabis research, this study concluded that “CBD slows the progression of many types of cancer, including breast, lung, prostate and colon cancer.” How that works is pretty incredible. CBD makes it harder for cancer cells to grow, and in some cases, this causes an increase in cancer cell death.
Drug Testing and CBD
A consumer who uses a high-quality, scientifically proven hemp-based CBD product at the standard serving size is highly unlikely to test positive for THC and/or THC-COOH. However, it’s important to be cognizant that extremely high doses may result in a positive urine screen (that would be subsequently shown to be false via GC/MS). Ultimately, consumers need to be fully informed of the specific regulations posed by their employers and adjust their consumption of cannabinoid products accordingly.
This “Drug Testing and CBD” is based on SAMHSA (Substance Abuse and Mental Health Services Administration) standards. Other organizations’ drug testing standards may vary, so keep in mind that the findings presented in this article may differ under alternative standards. If you have any concern about testing positive for THC when using CBD-containing hemp oil, please seek advice from your health care professional. Source: Leafy.com
- Gustafson RA, Kim I, Stout PR, Klette KL, George MP, Moolchan ET, Levine B, Huestis MA. Urinary pharmacokinetics of 11-nor-9-carboxy-delta9-tetrahydrocannabinol after controlled oral delta9-tetrahydrocannabinol administration. J Anal Toxicol. 2004 Apr; 28(3):160-7
- Gustafson RA, Levine B, Stout PR, Klette KL, George MP, Moolchan ET, Huestis MA. Urinary cannabinoid detection times after controlled oral administration of delta9-tetrahydrocannabinol to humans. Clin Chem. 2003 Jul; 49(7):1114-24.
- Kemp PM, Abukhalaf IK, Manno JE, Manno BR, Alford DD, Abusada GA. Cannabinoids in humans. I. Analysis of delta 9-tetrahydrocannabinol and six metabolites in plasma and urine using GC-MS. J Anal Toxicol. 1995 Sep; 19(5):285-91.
- Huestis MA, Mitchell JM, Cone EJ. Urinary excretion profiles of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans after single smoked doses of marijuana. J Anal Toxicol. 1996 Oct;20(6):441-52.
- Wall ME, Perez-Reyes M. J Clin Pharmacol. The metabolism of delta 9-tetrahydrocannabinol and related cannabinoids in man. 1981 Aug-Sep; 21(8-9 Suppl):178S-189S.